Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

14/07/2017 Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): Platelet-Rich Plasma and Mesenchymal Stem Cells 15/07/2013 A reporting guideline for clinical platelet transfusion studies from the BEST Collaborative 15/07/2013 Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis 12/07/2013 Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia 27/06/2013 Reporting genetic results in research studies: summary and recommendations of an NHLBI working group

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More